Ceapro Inc logo

CZO - Ceapro Inc Share Price

C$0.66 -0.1  -7.0%

Last Trade - 3:59pm

Micro Cap
Market Cap £30.4m
Enterprise Value £29.7m
Revenue £8.97m
Position in Universe 940th / 2682
Unlock CZO Revenue
Relative Strength (%)
1m -14.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -30.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
8.89 10.7 13.7 12.9 11.6 12.9 17.9 18.0 +7.7%
+796.2 +206.6 -37.4 -47.7
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Ceapro Increvenues increased 43% to C$8.9M. Net income totaled C$2.2Mvs. loss of C$1.2M. Revenues reflect Cosmeceutical Industrysegment increase of 3% to C$11K, United states segmentincrease of 50% to C$5.6M, Germany segment increase of 52%to C$2.3M. Net Income reflects Clinical studies decrease of64% to C$223K (expense), Foreign Exchange Gain increasefrom C$130K (expense) to C$104K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CZO
Graphical History


CZO Revenue Unlock CZO Revenue

Net Income

CZO Net Income Unlock CZO Revenue

Normalised EPS

CZO Normalised EPS Unlock CZO Revenue

PE Ratio Range

CZO PE Ratio Range Unlock CZO Revenue

Dividend Yield Range

CZO Dividend Yield Range Unlock CZO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CZO EPS Forecasts Unlock CZO Revenue
Profile Summary

Ceapro Inc is a Canada-based biotechnology company. The Company's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The Company is engaged in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Ceapro Inc supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. The Company operates in one reportable business segment, being the operations relating to the active ingredient product technology industry. Ceapro Inc has a production facility in Leduc, Alberta, Canada and research laboratories in Edmonton and Charlottetown, Prince Edward Island, Canada.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated April 1, 2016
Public Since February 5, 2015
No. of Shareholders: n/a
No. of Employees: 12
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange TSX Venture Exchange
Shares in Issue 77,611,341
Free Float (0.0%)
Eligible for
CZO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CZO
Upcoming Events for CZO
Frequently Asked Questions for Ceapro Inc
What is the Ceapro Inc share price?

As of 3:59pm, shares in Ceapro Inc are trading at C$0.66, giving the company a market capitalisation of £30.4m. This share price information is delayed by 15 minutes.

How has the Ceapro Inc share price performed this year?

Shares in Ceapro Inc are currently trading at C$0.66 and the price has moved by 0.103k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ceapro Inc price has moved by 0.102k% over the past year.

What are the analyst and broker recommendations for Ceapro Inc?

Of the analysts with advisory recommendations for Ceapro Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Ceapro Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Ceapro Inc next release its financial results?

Ceapro Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Ceapro Inc dividend yield?

Ceapro Inc does not currently pay a dividend.

Does Ceapro Inc pay a dividend?

Ceapro Inc does not currently pay a dividend.

When does Ceapro Inc next pay dividends?

Ceapro Inc does not currently pay a dividend.

How do I buy Ceapro Inc shares?

To buy shares in Ceapro Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ceapro Inc?

Shares in Ceapro Inc are currently trading at C$0.66, giving the company a market capitalisation of £30.4m.

Where are Ceapro Inc shares listed? Where are Ceapro Inc shares listed?

Here are the trading details for Ceapro Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: CZO
What kind of share is Ceapro Inc?

Based on an overall assessment of its quality, value and momentum, Ceapro Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Ceapro Inc share price forecast 2020?

Shares in Ceapro Inc are currently priced at C$0.66. At that level they are trading at 58.82% discount to the analyst consensus target price of 0.00.

Analysts covering Ceapro Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.044 for the next financial year.

How can I tell whether the Ceapro Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ceapro Inc. Over the past six months, the relative strength of its shares against the market has been 37.35%. At the current price of C$0.66, shares in Ceapro Inc are trading at 32.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ceapro Inc PE Ratio?

The Ceapro Inc PE ratio based on its reported earnings over the past 12 months is 26.88. The shares are currently trading at C$0.66.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Ceapro Inc?

We were unable to find the directors for Ceapro Inc.

Who are the major shareholders of Ceapro Inc?

Here are the top five shareholders of Ceapro Inc based on the size of their shareholding:

Zupancic (John) Individual Investor
Percentage owned: 2.32% (1.80m shares)
Gagnon (Gilles R) Individual Investor
Percentage owned: 2.05% (1.59m shares)
Rourke (Glenn) Individual Investor
Percentage owned: 1.48% (1.15m shares)
Oborowsky (Donald J) Individual Investor
Percentage owned: 1.34% (1.04m shares)
Li (William W. M.D.) Individual Investor
Percentage owned: 0.13% (102k shares)
Similar to CZO
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.